Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Novel model developed to predict amount of nicotine emitted from e-cigarettes

  • Depressed females have over-active glutamate receptor gene

  • Trying to quit smoking? First strengthen self-control

  • Take a Trip Through the Brain: New Imaging Tool

  • Positive reinforcement plays key role in cognitive task performance in ADHD kids

  • The body and the brain: Impact of mental, physical exertion on fatigue development

  • Depression, personality disorders drive psych patients to euthanasia

  • Seniors get mental health drugs at twice the rate of other adults, see psychiatrists less

  • Every country in the world can afford to support its smokers to stop

  • Depressive ruminations and the idling brain

  •